A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives
P&T
1 other identifier
interventional
632
1 country
1
Brief Summary
The goal of this study is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Nov 2012
Longer than P75 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 20, 2013
CompletedFirst Posted
Study publicly available on registry
September 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2017
CompletedJuly 9, 2018
July 1, 2018
4.3 years
August 20, 2013
July 6, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change in HIV medication adherence
6 month
change in frequency in attending HIV medical appointments
6 month
Secondary Outcomes (2)
change in sharing injection equipment
6 month
change in condom use
6 month
Study Arms (2)
Prevention & Testing Control
ACTIVE COMPARATORThe comparison condition is focused on basic HIV risk reduction , safety and preventing drug overdose.
Prevention & Testing Intervention
EXPERIMENTALThe intervention condition is training on peer outreach skills which includes talking to HIV positive social network members about HIV care, medication adherence and HIV risk reduction.
Interventions
6 group sessions, 1 individual session, and 1 dyad session
Eligibility Criteria
You may qualify if:
- Index
- years old or older
- documentation of HIV positive status
- report one of following risk behaviors in past 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex
- Testing network
- or older
- provided testing coupon provided by an index participant
- Longitudinal network participant-
- tested HIV negative at the Lighthouse via redeeming a testing coupon
- reported interacting with index who gave the coupon at least weekly
- report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex
- Positive Networks
- HIV positive
- report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex
You may not qualify if:
- Index- already enrolled in the study as a Network participant
- Testing network- already enrolled in the study as a Network participant
- Longitudinal network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant
- Positive network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lighhouse Studies @ Peer Point
Baltimore, Maryland, 21205, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Carl A Latkin, PhD
Johns Hopkins Bloomberg School of Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 20, 2013
First Posted
September 5, 2013
Study Start
November 1, 2012
Primary Completion
January 31, 2017
Study Completion
January 31, 2017
Last Updated
July 9, 2018
Record last verified: 2018-07